Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Accounts Payables: 2016-2021

Historic Accounts Payables for Monopar Therapeutics (MNPR) over the last 6 years, with Dec 2021 value amounting to $403,967.

  • Monopar Therapeutics' Accounts Payables rose 12.07% to $542,068 in Q3 2020 from the same period last year, while for Sep 2020 it was $542,068, marking a year-over-year increase of 12.07%. This contributed to the annual value of $403,967 for FY2021, which is 9.75% down from last year.
  • Per Monopar Therapeutics' latest filing, its Accounts Payables stood at $403,967 for FY2021, which was down 9.75% from $447,598 recorded in FY2020.
  • Over the past 5 years, Monopar Therapeutics' Accounts Payables peaked at $724,165 during FY2019, and registered a low of $311,867 during FY2017.
  • Over the past 3 years, Monopar Therapeutics' median Accounts Payables value was $447,598 (recorded in 2020), while the average stood at $525,243.
  • Per our database at Business Quant, Monopar Therapeutics' Accounts Payables skyrocketed by 383.44% in 2017 and then tumbled by 38.19% in 2020.
  • Over the past 5 years, Monopar Therapeutics' Accounts Payables (Yearly) stood at $311,867 in 2017, then grew by 28.12% to $399,551 in 2018, then surged by 81.24% to $724,165 in 2019, then plummeted by 38.19% to $447,598 in 2020, then declined by 9.75% to $403,967 in 2021.